Supporting this idea, IP6 also shows beneficial effects in cancer [402,403], through promotion of apoptosis and inhibition of cell proliferation, survival and angiogenesis, which was attributed to suppression of the Akt/mTOR and PI3K/Akt signalling pathways [404–407]. The gene discussed is PIK3CA; the disease is cancer.